This Tetraphase Pharma Analyst Expects Positive Data In Mid-2015 By: Benzinga via Benzinga April 28, 2015 at 07:14 AM EDT In a report published Tuesday, analysts at Brean Capital maintained their Buy rating on Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH). ... Read More >> Related Stocks: Tetraphase Pharmaceu